// App-Quantinova.ai

T5204 2016 AHA : Rivaroxaban and Improved Modified Rankin Scale Score Among Patients With Acute Coronary Syndrome who Experience Stroke - Insights From the ATLAS ACS-2-TIMI-51 Clinical Trial

Researchers

Presenter

  • Serge Korjian

Principal Investigators

  • Jessica L. Mega

  • Alexei N. Plotnikov

  • Paul Burton

  • Eugene Braunwald

  • C. Michael Gibson

Medical Centers

  • Beth Israel Deaconess Medical Center, Boston, MA

  • Brigham & Women's Hospital, Boston, MA

Locations

  • United States

Companies

  • Johnson & Johnson Se

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Intracerebral hemorrhage

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Evithrom

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • randomized

  • double blind/blinded

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved